Thank you but that doesn't actually make it any clearer. The CD16 protocol will be finalized with the US FDA and then we are going to run CD17 and CD18 trials elsewhere in the world? Will they be the same protocol?

My understanding was that CD16 was for under 65 and CD17 was supposed to be over 65. Will Brazil be one trial (CD17 for example) and India another? I'm not sure if this was intentionally word salad but I can't make heads or tails of it.